Tech Company Financing Transactions

Actio Biosciences Funding Round

Actio Biosciences, operating out of San Diego, secured $55 million from Canaan Partners, Droia Ventures and Deerfield Management Company.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
Actio is leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases. The company's platform comprises a vast proprietary target database, called the Rare Disease Target Atlas, and expertise in bioinformatics, biology and chemistry.

Company Information

Company Status
Private & Independent
Mailing Address
9310 Athena Circle 100
San Diego, CA 92037
Email Address
Actio was founded by leaders in genetics and drug development to push the boundaries of how we translate genetic insights into new medicines. Actio is more than a precision medicine company -- we have a bold vision to take learnings in how we pinpoint targets and develop drugs for homogenous rare disease populations and leverage those learnings to identify underlying biology in heterogenous common disease populations. Through our unique approach, we aim to bring meaningful new therapeutics from one to many.
Actio Biosciences LinkedIn Company Profile
Social Media
Actio Biosciences Company Twitter Account
Company News
Actio Biosciences News
Actio Biosciences on Facebook
Actio Biosciences on YouTube

Management Team

Email & Social
    LinkedIn Profile    Twitter Account    News    on Facebook
Chief Executive Officer
David Goldstein
  David Goldstein LinkedIn Profile  David Goldstein Twitter Account  David Goldstein News  David Goldstein on Facebook
Chief Scientific Officer
David Breckenridge
  David Breckenridge LinkedIn Profile  David Breckenridge Twitter Account  David Breckenridge News  David Breckenridge on Facebook
John McHutchison
  John McHutchison LinkedIn Profile  John McHutchison Twitter Account  John McHutchison News  John McHutchison on Facebook



Browse more venture capital transactions:

Prev: 9/14/2023: EquipmentShare venture capital transaction
Next: 9/14/2023: Flipto venture capital transaction


Share this article


News on VC Transactions

We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary